Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Enterprise Value (2018 - 2019)

Historic Enterprise Value for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q3 2019 value amounting to -$9.7 million.

  • DiaMedica Therapeutics' Enterprise Value fell 14994.87% to -$9.7 million in Q3 2019 from the same period last year, while for Sep 2019 it was -$9.7 million, marking a year-over-year decrease of 14994.87%. This contributed to the annual value of -$16.8 million for FY2018, which is N/A changed from last year.
  • As of Q3 2019, DiaMedica Therapeutics' Enterprise Value stood at -$9.7 million, which was down 14994.87% from -$11.0 million recorded in Q2 2019.
  • Over the past 5 years, DiaMedica Therapeutics' Enterprise Value peaked at -$3.9 million during Q3 2018, and registered a low of -$16.8 million during Q4 2018.